Insightful Alzheimer’s Disease Treatment Market Report 2025 – For Product, Marketing, and Strategy Teams

 Unlock 30% off global market reports with code ONLINE30 – get insights on tariff changes, macro trends, and global economic shifts.

How has the alzheimer’s disease treatment market size changed in recent years, and what is the outlook ahead?
The alzheimer’s disease treatment market size has grown strongly in recent years. It will grow from $5.93 billion in 2024 to $6.41 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to advancements in research and understanding, drug approvals and market entry, government initiatives and funding, public awareness and education.

The alzheimer’s disease treatment market size is expected to see strong growth in the next few years. It will grow to $8.35 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to precision medicine approaches, rising healthcare expenditure, global burden of disease, genetic and biomarker research, emerging markets. Major trends in the forecast period include biotechnological breakthroughs, technological innovations, digital health technologies, precision medicine approaches, neuroinflammation modulation, collaborations and partnerships.

Download Your Free Sample PDF:
Alzheimer’s Disease Treatment Market Report 2025

What are the top economic and technological drivers pushing alzheimer’s disease treatment market growth?
The increasing cases of Alzheimer's are a major factor contributing to the growth of the Alzheimer’s disease treatment market. Alzheimer's is the most common type of dementia. The USA Alzheimer's Association expects that all the states in the US are projected to face a rise of at least 14% in the number of Alzheimer’s patients by 2025 due to the increase in the geriatric population. At the global level, the estimated new cases of Alzheimer’s are expected to grow by 35% to 615,000 by 2030, and by 110% to 959,000 by 2050. Therefore, the increasing prevalence of Alzheimer’s disease is expected to drive the demand of the growth of global Alzheimer’s disease treatment market.

How is the alzheimer’s disease treatment market segmented by product, application, and end-user?
The alzheimer’s disease treatment market covered in this report is segmented –

1) By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins
2) By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists
3) By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics

Subsegments:
1) By Cholinergic: Donepezil, Galantamine, Rivastigmine
2) By Memantine: Memantine Hydrochloride, Extended-Release Memantine
3) By Combined Drug: Donepezil and Memantine Combination
4) By AChE Inhibitors: Tacrine, Physical Inhibitors
5) By Immunoglobulins: IVIG (Intravenous Immunoglobulin), Monoclonal Antibodies

View The Full Market Report:
Alzheimer’s Disease Treatment Market Report 2025

What evolving trends are creating new opportunities in the alzheimer’s disease treatment market?
Major companies operating in the Alzheimer's disease treatment market are focusing on regulatory approvals to gain a competitive edge and enhance their product offerings. Regulatory approvals refer to the formal authorization granted by government agencies, such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA), for a product to be marketed and sold to the public. For instance, in July 2024, Eli Lilly and Company, a US-based pharmaceutical company, received FDA approval for its Alzheimer's treatment, Kisunla (donanemab-azbt), which is indicated for adults with early symptomatic Alzheimer's disease, including those with mild cognitive impairment and mild dementia. The drug is administered via monthly intravenous infusion and has demonstrated efficacy in slowing the progression of the disease in clinical trials. The approval reflects its potential impact, having received Fast Track, Priority Review, and Breakthrough Therapy designations.

Which leading companies are dominating the alzheimer’s disease treatment market landscape?
Major companies operating in the alzheimer’s disease treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Merck Sharp & Dohme Corp., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., UCB S.A., Eisai Co. Ltd., Forest Laboratories LLC, Ono Pharmaceutical Co. Ltd., H. Lundbeck A/S, Allergan plc, Luye Pharma Group, Avanir Pharmaceuticals Inc., Denali Therapeutics Inc., Athira Pharma Inc., ProMIS Neurosciences Inc., AC Immune SA, vTv Therapeutics Inc., AB Science SA, TauRx Pharmaceuticals Ltd., Alzheon Inc.

Which geographic areas are expected to offer the highest growth opportunities in thealzheimer’s disease treatment market?
The countries covered in the Alzheimer’s disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

How Can Companies Use The Alzheimer’s Disease Treatment Market Report to Drive Business Results?
This report provides actionable insights tailored for business use—not academic analysis. Companies can leverage the data to:
• Time market entry or expansion using growth forecasts and CAGR trends.
• Develop competitive products by tracking key technology shifts and user preferences.
• Tailor regional strategies with in-depth geographic data and local market dynamics.
• Benchmark and plan partnerships using competitive landscape insights.

Purchase The Report And Get A Swift Delivery:
Alzheimer’s Disease Treatment Market Report 2025

Need Customized Data On Alzheimer’s Disease Treatment Market?
For companies needing more tailored intelligence, The Business Research Company offers customized consulting and data services. Whether you're entering new regions, launching innovative products, or assessing M&A opportunities, our experts can develop actionable insights specific to your business objectives.

Request Customized Data:
Alzheimer’s Disease Treatment Market Report 2025

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:

The Business Research Company

Market Research Reports

Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info


Follow Us On:

LinkedIn: The Business Research Company | LinkedIn